Effect of Methionine Enkephalin on Natural Killer Cell and Cytotoxic T Lymphocyte Activity in Mice Infected with Influenza a Virus

References

• Glezen W. P., Couch R. P. Influenza Viruses, in Viral Infections of Humans: Epidemiology and Control, A. S. Evans. Plenum Press, New York 1989; 419
   Google Scholar
• Sidwell R. W., Huffman J. H., Moscon B. J., Warren R. P. Influenza Virus-Inhibitory Effects of Intraperitoneally and Aerosol-Administered Sp-303. A Plant Flavonoid, Chemotherapy 1994; 40: 42
   PubMedGoogle Scholar
• Sidwell R. W., Huffman J. H., Gilbert J., Moscon B., Pedersen G., Burger R. A., Warren R. P. Utilization of Pulse Oximetry for the Study of the Inhibitory Effects of Antiviral Agents on influenza Virus in Mice. Antimicrob. Agents Chemother. 1992; 36: 473
   PubMed Web of Science ®Google Scholar
• Sidwell R. W., Huffman J. H., Call E. W., Alaghamandan H., Cook P. D., Robins R. K. Effect of Selenazofurin on Influenza A and B Virus infections of Mice. Antiviral Res. 1986; 6: 343
   PubMedGoogle Scholar
• Sidwell R. W., Huffman J. H., Call E. W., Alaghamandan H., Cook P. D. Activity of Selenazofurin Against Influenza A and B Viruses in Vitro. Antimicrob. Agents Chemother. 1985; 28: 375
   PubMedGoogle Scholar
• Herrmann J. E., Bruns M., West K., Ennis F. A. Efficacy of Rimantadine Hydrochloride in the Treatment of Influenza Infection of Mice. Antiviral Res. 1989; 11: 127
   PubMedGoogle Scholar
• Iinuma H., Nerome K., Yoshioka Y., Okinaga K. Characteristics of Cytotoxic T-Lymphocytes Directed to Influenza-Virus Hemagglutinin Elicited by Immunization with Muramyldipeptide-Influenza Liposome Vaccine. Scand. J. Immunol. 1995; 41: 1
   PubMed Web of Science ®Google Scholar
• Fiebach N., Beckett W. Prevention of Respiratory-Infections in Adults: Influenza and Pneumococcal Vaccines. Arch. Intern. Med. 1994; 154(22)2545
   PubMedGoogle Scholar
• Bertagnolli M. M., Lin B. Y., Young D., Herrmann S. H. IL-12 Augments Antigen-Dependent Proliferation of Activated T Lymphocytes. J. Immunol 1992; 149: 3778
   PubMed Web of Science ®Google Scholar
• Sarawar S. R., Sangster M., Coffman R. L., Doherty P. C. Administration of Anti-IFN-Gamma Antibody to Beta 2-Microglobulin-Deficient Mice Delays Influenza Virus Clearance but Does Not Switch the Response to a T Helper Cell 2 Phenotype. J. Immunol. 1994; 153: 1246
   PubMedGoogle Scholar
• Hennet T., Ziltener H. J., Frei K, Peterhans E. J. A Kinetic Study of Immune Mediators in the Lungs of Mice Infected with Influenza A Virus. Immunol. 1992; 149: 932
   Google Scholar
• Chomel J. J., Simon-Lavoine N., Thouvenot D., Valette M., Choay J., Chedid L., Aymard M. Prophylactic and Therapeutic Effects of Murabutide in Mice Infected with Influenza A/H3N2(A/Texas/l/77) Virus, 3. Biol. Resp. Mod. 1988; 7: 581
   PubMedGoogle Scholar
• House R. V., Pearson F. C., Thomas P. T. Selective Potentiation of Host Resistance in Mice following Treatment with Pyrexol. Mol. Biother. 1990; 2: 175
   PubMedGoogle Scholar
• Turowski R. C., Triozzi P. L. Application of Chemical Immunomodulators to the Treatment of Cancer and Aids. Cancer Invest. 1994; 12: 620
   PubMed Web of Science ®Google Scholar
• Yap K. L., Ada G. L., McKenzie I. F. C. Transfer of Specific Cytotoxic T Lymphocytes Protects Mice Inoculated with Influenza Viruses. Nature 1978; 273: 238
   PubMed Web of Science ®Google Scholar
• Morris A. G., Lin Y. L., Askonas B. D. Immune Interferon Release When a Cloned Cytotoxic T Cell Line Meets its Correct Influenza Infected Target Cell. Nature 1982; 295: 150
   PubMedGoogle Scholar
• Wells M. A., Daniel S., Djeu J. Y., Kiley S. C., Eunis F. A. Recovery From a Viral Respiratory Tract Infection: IV. Specificity of Protection by Cytotoxic T Lymphocytes. J. Immunol 1983; 130: 2908
   PubMedGoogle Scholar
• Stein-Strelein J., Bennett M., Mann D., Kumar V. Natural Killer Cells In Mouse Lung: Surface Phenotype, Target Preference and Response to Local Influenza Virus Infection. J. Immunol. 1983; 131: 2699
   PubMedGoogle Scholar
• Sastry K. J., Bender B. S., Bell W., Small P. A., Jr, Arlinghaus R. B. Effects of Influenza Virus-Specific Cytotoxic T-Lymphocyte Responses Induced by a Synthetic Nucleoprotein Peptide on the Survival of Mice Challenged with a Lethal Dose of Virus. Vaccine 1994; 12: 1281
   PubMedGoogle Scholar
• Masihi K. N., Lange W., Rohde-Schulz B. Modulation of Natural Killer Cytotoxicity by Muramyl Dipeptide and Trehalose Dimycolate Incorporated in Squalane Droplets. Cancer Immunol. Immunother. 1987; 24: 19
   PubMedGoogle Scholar
• Plotnikoff N. P., Miller G. C. Enkephalins as Immunomodulators. Int. J. Immunopharmacol. 1983; 5: 437
   PubMed Web of Science ®Google Scholar
• Wybran J., Schandene L., Van Vooren J. P., Vandermoten G., Latinne D., Sonnect J., DeBruyere M., Taelman H., Plotnikoff N. P. Immunologic Properties of Methionine-Enkephalin and Therapeutic Implications in AIDS, ARC and Cancer. Ann. N. Y. Acad. Sci. 1987; 496: 108
   PubMed Web of Science ®Google Scholar
• Wybran J., Appleboom T., Famaey J. F., Govaert A. Suggestive Evidence for Morphine and Methionine Enkephalin Receptors on Normal Blood T Lymphocytes. J. Immunol. 1979; 123: 1068
   PubMed Web of Science ®Google Scholar
• Singh S., Singh P. P., Dhawan V. C., Haq W., Mathur K. B., Dutta G. P., Srimal R. C., Dhawan B. N. Lymphokines Production by Concanavalin A-Stimulated Mouse Splenocytes: Modulation by Met-enkephalin and a Related Peptide. Immunopharmocology 1994; 27: 245
   PubMedGoogle Scholar
• Apte R. N., Durum S. K., Oppenheim J. J. Opioids Modulate Interleukin-1 Production and Secretion by Bone-Marrow Macrophages. Immunol. Lett. 1990; 24: 141
   PubMed Web of Science ®Google Scholar
• Hagi K., Uno K., Inaba K., Muramatsu S. Augmenting Effect of Opioid Peptides on Murine Macrophage Activation. J. Neuroimmunol 1994; 50: 71
   PubMedGoogle Scholar
• Hucklebridge F. H., Hudspith B. N., Lydyard P. M., Brostoff J. Stimulation of Human Peripheral Lymphocytes by Methionine Enkephalin and Delta-Selective Opioid Analogues. Immunopharmacology 1990; 19: 87
   PubMedGoogle Scholar
• Yang S. X., Li X. Y. Influence of Methionine-Enkephalin on Interleukin-2 production and Interleukin-2 Receptor Expression. Chung Kuo Yao Li Hsueh Pao 1992; 13: 131
   PubMedGoogle Scholar
• Wybran J., Plotnikoff N. P. Methionine Enkephalin, A New Lymphokine for the Treatment of ARC Patients. Stress and Immunity, N. P. Plotnikoff, A. J. Murgo, R. W. Faith. CRC Press, Boca Raton 1991; 417
   Google Scholar
• Braciale T. J. Immunologic Recognition of Influenza Virus-Infected Cells. Cell. Immunol. 1977; 33: 423
   PubMedGoogle Scholar
• Sidwell R. W., Smee D. F., Warren R. P., Huffman J. H., Gilbert B. J., Burger R. A., Pearson F. C. Murine Cytomegalovirus-Inhibitory Effects of Imuvert. Antiviral Res. 1993; 20: 279
   PubMedGoogle Scholar
• Trinchieri G. Biology of Natural Killer Cells. Adv. Immunol. 1989; 47: 187
   PubMed Web of Science ®Google Scholar
• Plotkin S. A., Wabuke-Bunoti M. A., Bennink J. R. Influenza Virus-Induced Encephalopathy in Mice: Interferon Production and Natural Killer Cell Activity During Acute Infection. J. Virol. 1986; 60: 1062
   PubMedGoogle Scholar
• Saito R., Ruffman R., Welker R. D., Herberman R. B., Chirigos M. A. Development of Hyporesponsiveness of Natural Killer Cells to Augmentation of Activity after Multiple Treatments with Biological Response Modifiers. Cancer Immunol. Immunother. 1985; 19: 130
   PubMed Web of Science ®Google Scholar
• Wybran J., Schandene L. Some Immunological Effects of Methionine-Enkephaline in Man: Potential Therapeutical Use. Leukocytes and Host Defense, R. Rosen. Alan R. Liss, NY 1986; 205
   Google Scholar
• Murgo A. J. Inhibition of B16-B16 Melanoma Growth in Mice By Methionine-Enkephalin. J. Natl. Cancer Inst. 1985; 75: 341
   PubMedGoogle Scholar
• Zagon I. S., McLaughlin P. J., Goodman S. R., Rhodes R. E. Opioid Receptors and Endogenous Opioids in Diverse Human and Animal Cancers. J. Natl. Cancer Inst. 1987; 79: 1
   PubMedGoogle Scholar
• Sidwell R. W., Smee D. F., Huffman J. H., Baily R. P., Warren R. P., Burger R. A., Penny C. L. Antiviral Activity of an Immunomodulatory Lipophilic Desmuramyl MDP Analog. Antiviral Res. 1995, (In Press)
   Google Scholar